Variants in the fetal genome near FLT1 are associated with risk of preeclampsia
Ralph McGinnisWellcome Trust Sanger Institute, Cambridge, UKValgerður SteinthórsdóttirdeCODE Genetics/Amgen, Reykjavik, IcelandNicholas WilliamsWellcome Trust Sanger Institute, Cambridge, UKGuðmar ÞorleifssondeCODE Genetics/Amgen, Reykjavik, IcelandScott ShooterWellcome Trust Sanger Institute, Cambridge, UKSigrun HjartardottirDepartment of Obstetrics and Gynecology, Landspitali University Hospital, Reykjavik, IcelandSuzannah BumpsteadWellcome Trust Sanger Institute, Cambridge, UKLilja StefánsdóttirdeCODE Genetics/Amgen, Reykjavik, IcelandLucy HildyardWellcome Trust Sanger Institute, Cambridge, UKJon K. SigurdssondeCODE Genetics/Amgen, Reykjavik, IcelandJohn P. KempMRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UKGabriela B. SilvaCentre of Molecular Inflammation Research (CEMIR) and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, NorwayLiv Cecilie Vestrheim ThomsenCentre of Molecular Inflammation Research (CEMIR) and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, NorwayTiina JääskeläinenMedical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandEero KajantieChildren's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandSally ChappellSchool of Life Sciences, University of Nottingham, Nottingham, UKNoor KalshekerSchool of Life Sciences, University of Nottingham, Nottingham, UKAshley MoffettDepartment of Pathology, University of Cambridge, Cambridge, UKSusan E. HibyDepartment of Pathology, University of Cambridge, Cambridge, UKWai LeeBHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UKSandosh PadmanabhanBHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UKNigel SimpsonLeeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UKVivien A. DolbyLeeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UKEleonora Staines-UriasDepartment of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UKStephanie M. EngelDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USAA. HauganNorwegian Institute of Public Health, Oslo, NorwayLill TrogstadNorwegian Institute of Public Health, Oslo, NorwayGulnara SvyatovaScientific Center of Obstetrics, Gynecology and Perinatology, Almaty, KazakhstanNodira ZakhidovaInstitute of Immunology, Uzbek Academy of Sciences, Tashkent, UzbekistanDilbar NajmutdinovaRepublic Specialized Scientific Practical Medical Centre of Obstetrics and Gynecology, Tashkent, UzbekistanAnna F. DominiczakBHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UKHåkon K. GjessingDepartment of Global Public Health and Primary Care, University of Bergen, Bergen, NorwayJuan P. CasasFarr Institute of Health Informatics, University College London, London, UKFrank DudbridgeDepartment of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UKJames J. WalkerLeeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UKFiona Broughton PipkinMedical School, University of Nottingham, Nottingham, UKUnnur ÞorsteinsdóttirFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, IcelandReynir Tómas GeirssonDepartment of Obstetrics and Gynecology, Landspitali University Hospital, Reykjavik, IcelandDebbie A. LawlorMRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UKAnn‐Charlotte IversenCentre of Molecular Inflammation Research (CEMIR) and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, NorwayPer MagnusNorwegian Institute of Public Health, Oslo, NorwayHannele LaivuoriInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, FinlandKāri StefánssonFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, IcelandLinda MorganSchool of Life Sciences, University of Nottingham, Nottingham, UK
ABI
Аннотация
Аннотация отсутствует.